These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19486486)

  • 21. Some empirical notes on the epo epidemic in professional cycling.
    Lodewijkx HF; Brouwer B
    Res Q Exerc Sport; 2011 Dec; 82(4):740-54. PubMed ID: 22276416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Doping in high-level athletes].
    Chalchat B
    Ann Pharm Fr; 2002 Sep; 60(5):303-9. PubMed ID: 12378138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Race weight: perceptions of elite female road cyclists.
    Haakonssen EC; Martin DT; Jenkins DG; Burke LM
    Int J Sports Physiol Perform; 2015 Apr; 10(3):311-7. PubMed ID: 25203649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vanity of doping].
    Kiefer B
    Rev Med Suisse; 2012 Sep; 8(353):1752. PubMed ID: 23029994
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction profiles for nutritional supplement use among young German elite athletes.
    Dietz P; Ulrich R; Niess A; Best R; Simon P; Striegel H
    Int J Sport Nutr Exerc Metab; 2014 Dec; 24(6):623-31. PubMed ID: 24901677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in blood values in elite cyclist.
    Mørkeberg JS; Belhage B; Damsgaard R
    Int J Sports Med; 2009 Feb; 30(2):130-8. PubMed ID: 18773375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of hemoglobin mass during a 6-day UCI ProTour cycling race.
    Garvican LA; Eastwood A; Martin DT; Ross ML; Gripper A; Gore CJ
    Clin J Sport Med; 2010 May; 20(3):200-4. PubMed ID: 20445361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeine: use and abuse in sports.
    Delbeke FT; Debackere M
    Int J Sports Med; 1984 Aug; 5(4):179-82. PubMed ID: 6480201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The social-cognitive mechanisms regulating adolescents' use of doping substances.
    Lucidi F; Zelli A; Mallia L; Grano C; Russo PM; Violani C
    J Sports Sci; 2008 Mar; 26(5):447-56. PubMed ID: 18274942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doping destroys the story at the heart of cycling.
    Riley S
    Nature; 2007 Sep; 449(7160):281. PubMed ID: 17882200
    [No Abstract]   [Full Text] [Related]  

  • 31. [Amphetamine doping in leisure-time mountain climbing at a medium altitude in the Alps].
    Röggla G; Röggla M; Zeiner A; Röggla H; Deusch E; Wagner A; Hibler A; Haber P; Laggner AN
    Schweiz Z Sportmed; 1993 Sep; 41(3):103-5. PubMed ID: 8211079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An alternative approach to the prevention of doping in cycling.
    Aubel O; Ohl F
    Int J Drug Policy; 2014 Nov; 25(6):1094-102. PubMed ID: 25440912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doping in cyclism: results of unannounced controls in Flanders (1987-1994).
    Delbeke FT
    Int J Sports Med; 1996 Aug; 17(6):434-8. PubMed ID: 8884418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes towards doping and related experience in Spanish national cycling teams according to different Olympic disciplines.
    Morente-Sánchez J; Mateo-March M; Zabala M
    PLoS One; 2013; 8(8):e70999. PubMed ID: 23990919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs, recreational drug use and attitudes towards doping of high school athletes.
    Laure P; Lecerf T; Friser A; Binsinger C
    Int J Sports Med; 2004 Feb; 25(2):133-8. PubMed ID: 14986197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qualitative evidence of a primary intervention point for elite athlete doping.
    Mazanov J; Huybers T; Connor J
    J Sci Med Sport; 2011 Mar; 14(2):106-10. PubMed ID: 20708965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key influences on motivations for utility cycling (cycling for transport to and from places).
    Heesch KC; Sahlqvist S
    Health Promot J Austr; 2013 Dec; 24(3):227-33. PubMed ID: 24355344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competition stress in sport performers: stressors experienced in the competition environment.
    Mellalieu SD; Neil R; Hanton S; Fletcher D
    J Sports Sci; 2009 May; 27(7):729-44. PubMed ID: 19424897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of nutritional supplements among master athletes.
    Striegel H; Simon P; Wurster C; Niess AM; Ulrich R
    Int J Sports Med; 2006 Mar; 27(3):236-41. PubMed ID: 16541381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High-performance society and doping].
    Gallien CL
    Ann Pharm Fr; 2002 Sep; 60(5):296-302. PubMed ID: 12378137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.